Activation of LXRα induces lipogenesis in HaCaT cells

Arch Pharm Res. 2010 Sep;33(9):1443-9. doi: 10.1007/s12272-010-0919-5. Epub 2010 Oct 14.

Abstract

The oxysterol nuclear receptors, LXRα (liver X receptor α; NR1H3) and LXRβ (NR1H2), coordinately regulate the expression of genes involved in lipid metabolism, anti-inflammation, and cholesterol transport. Previous studies have demonstrated that ligands of LXRα are important in the maintenance of the normal epidermal barrier function and keratinocyte differentiation. In this study, we examined whether LXRα and its ligands regulate lipid synthesis in HaCaT cells, a spontaneously transformed human keratinocyte cell line. When HaCaT cells were treated with the LXRα ligand TO901317, lipid droplets accumulated in the majority of cells, which were stained by Oil Red O. A luciferase reporter construct containing the LXR response element was activated about fourfold in HaCaT cells by TO901317 treatment, suggesting that LXR has a role in lipid synthesis in these cells. The expression of LXRα target genes, such as those encoding sterol regulatory binding protein and fatty acid synthase, were induced time dependently by TO901317, as measured by RT-PCR and western blotting. The expression of PPAR-α, -β, and -γ which regulate lipid metabolism, was also increased by TO901317 treatment. In contrast, TO901317 reduced the lipopolysaccharide-induced expression of cyclooxygenase 2 and inducible nitric oxide synthase in HaCaT cells. These results indicate that LXRα activation leads to lipogenesis in keratinocytes, which may enhance the epidermal barrier function of the skin.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Anti-Inflammatory Agents, Non-Steroidal / pharmacology*
  • Cell Line, Transformed
  • Fatty Acid Synthases / genetics
  • Fatty Acid Synthases / metabolism
  • Gene Expression Regulation / drug effects
  • Genes, Reporter
  • Humans
  • Hydrocarbons, Fluorinated / pharmacology*
  • Keratinocytes / drug effects*
  • Keratinocytes / metabolism*
  • Keratinocytes / pathology
  • Ligands
  • Lipid Metabolism / drug effects
  • Lipogenesis / drug effects*
  • Lipopolysaccharides / antagonists & inhibitors
  • Lipopolysaccharides / toxicity
  • Liver X Receptors
  • Orphan Nuclear Receptors / genetics
  • Orphan Nuclear Receptors / metabolism*
  • Peroxisome Proliferator-Activated Receptors / genetics
  • Peroxisome Proliferator-Activated Receptors / metabolism
  • RNA, Messenger / metabolism
  • Response Elements / drug effects
  • Reverse Transcriptase Polymerase Chain Reaction
  • Sterol Regulatory Element Binding Protein 1 / genetics
  • Sterol Regulatory Element Binding Protein 1 / metabolism
  • Sulfonamides / pharmacology*
  • Time Factors

Substances

  • Anti-Inflammatory Agents, Non-Steroidal
  • Hydrocarbons, Fluorinated
  • Ligands
  • Lipopolysaccharides
  • Liver X Receptors
  • NR1H2 protein, human
  • NR1H3 protein, human
  • Orphan Nuclear Receptors
  • Peroxisome Proliferator-Activated Receptors
  • RNA, Messenger
  • Sterol Regulatory Element Binding Protein 1
  • Sulfonamides
  • T0901317
  • Fatty Acid Synthases